3.46
Aurora Cannabis Inc. stock is traded at $3.46, with a volume of 414.23K.
It is down -2.81% in the last 24 hours and down -8.95% over the past month.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
See More
Previous Close:
$3.56
Open:
$3.57
24h Volume:
414.23K
Relative Volume:
0.46
Market Cap:
$204.58M
Revenue:
$267.06M
Net Income/Loss:
$-69.17M
P/E Ratio:
-3.0603
EPS:
-1.1306
Net Cash Flow:
$-22.38M
1W Performance:
+4.22%
1M Performance:
-8.95%
6M Performance:
-17.81%
1Y Performance:
-36.98%
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ACB
Aurora Cannabis Inc.
|
3.46 | 210.49M | 267.06M | -69.17M | -22.38M | -1.1306 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Dec-11-24 | Initiated | TD Cowen | Buy |
| Feb-09-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now - The Motley Fool
Aurora Cannabis Inc. stock falls Friday, underperforms market - MarketWatch
Should You Buy CGC Stock After Marijuana Reclassification? - The Globe and Mail
Aurora Cannabis Inc. stock rises Thursday, outperforms market - MarketWatch
Aurora Cannabis (ACB) plans Aug. 7, 2026 virtual annual meeting - Stock Titan
ACB.CA Stock Price, Quote & Chart | AURORA CANNABIS INC (TSX:ACB) - ChartMill
Aurora Cannabis Inc. stock rises Wednesday, outperforms market - MarketWatch
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information - Quantisnow
Aurora Cannabis Inc. stock falls Monday, underperforms market - MarketWatch
Cannabis Pharmaceuticals Business Research Report 2026: An - GlobeNewswire
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth - Yahoo Finance
Number of shareholders of Aurora Cannabis Inc. – DUS:21P - TradingView
Aurora granted Plant Breeders' Rights in Canada - MMJDaily
ACB Stock Chart | AURORA CANNABIS INC (NASDAQ:ACB) - ChartMill
Aurora Cannabis Granted Plant Breeders' Rights for Two Cultivars - Cannabis Equipment News
Aurora Granted Plant Breeders’ Rights for Farm Gas, Driftwood Diesel - StratCann
Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science - Cannabis Business Times
Aurora Cannabis Secures Canadian Plant Breeders’ Rights for Key Medical Cultivars - TipRanks
Europe’s Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets - marketscreener.com
Europe's Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets - FinancialContent
Aurora Cannabis (ACB) secures Canadian Plant Breeders’ Rights on key cultivars - Stock Titan
Two New Cultivars For Aurora Cannabis (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis IncGranted Plant Breeders' Rights In Canada For Two Proprietary Cultivars - TradingView
Aurora Cannabis Inc. stock falls Tuesday, underperforms market - MarketWatch
Best Cannabis Stocks To Follow TodayMay 10th - MarketBeat
Aurora Cannabis (NASDAQ:ACB) Raised to "Sell" at Wall Street Zen - MarketBeat
Top Cannabis Stocks To Watch TodayMay 8th - MarketBeat
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Aurora’s Global Cannabis Push Lifts TSX Smallcap Index Focus - Kalkine Media
Should SNDL Stock Be in Your Portfolio Post Q1 Earnings? - TradingView
Aurora Cannabis (NASDAQ:ACB) Stock Price Up 0.6%Here's Why - MarketBeat
Cannabis stock ACB down 19% YTD: Should you buy the dip? - MSN
Medical Cannabis Market Will Generate Booming Growth - openPR.com
Aurora Cannabis Inc. stock rises Friday, outperforms market - MarketWatch
Aurora Cannabis Inc. stock falls Wednesday, underperforms market - MarketWatch
Potent Cannabis Portfolio Expansions - Trend Hunter
US Cannabis Market Report Analysis Report 2026-2034 Featuring Canopy Growth, Tilray Brands, Curaleaf, Aurora Cannabis, Jazz Pharma, GTI, Trulieve, Cresco Labs, Organigram Global, TerrAscend - Yahoo Finance
Aurora Cannabis Expands Global Medical Portfolio With New Launches Across Canada, Europe and Australia - TipRanks
New Aurora (NASDAQ: ACB) medical cannabis launches span 4 markets - Stock Titan
Aurora Cannabis expands medical product lineup globally By Investing.com - Investing.com South Africa
Aurora Cannabis expands medical product lineup globally - Investing.com India
Aurora Cannabis expands medical portfolio across global markets - StreetInsider
Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets - ChartMill
Aurora Cannabis acquires Safari Flower Company for C$26.5M - MSN
Aurora Cannabis Inc. stock rises Monday, outperforms market - MarketWatch
Top Cannabis Stocks To Follow NowApril 27th - MarketBeat
Aurora Cannabis drops despite Q4 beat amid concerns over international growth - MSN
Aurora Cannabis drops as margin contraction drives Q1 loss - MSN
Will cannabis giants turn green this quarter: Here's what to expect - MSN
Aurora Cannabis Inc. Trade Ideas — BOATS:ACB - TradingView
Aurora Cannabis (OTCMKTS:ACBFF) Trading Down 13.7%Here's Why - MarketBeat
Aurora Cannabis Inc. Stock (ACB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):